HAE Stock HAE is expected to report earnings to fall -14.3% to 89 cents per share on May 09

A.I.dvisor
at Tickeron.com
05/08/24
Loading...
HAE - Haemonetics Corp
Haemonetics Corp Earnings Graph
Q1'24
Est.
$0.89
Q4'23
Beat
by $0.10
Q3'23
Beat
by $0.10
Q2'23
Beat
by $0.32
Q1'23
Beat
by $0.07
The last earnings report on December 31 showed earnings per share of $1.04, beating the estimate of 94 cents. P/B Ratio (4.564) is normal, around the industry mean (22.483). P/E Ratio (34.467) is within average values for comparable stocks, (82.064). Projected Growth (PEG Ratio) (1.624) is also within normal values, averaging (5.589). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.428) is also within normal values, averaging (51.692). With 768.80K shares outstanding, the current market capitalization sits at 4.33B.
View a ticker or compare two or three
HAEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of blood processing systems

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
125 Summer Street
Phone
+1 781 848-7100
Employees
3034
Web
https://www.haemonetics.com